Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasm Metastasis 4Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Radiation Pneumonitis 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Locally Advanced Cervical Carcinoma 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Cisplatin 51Gemcitabine 28Radiotherapy, Intensity-Modulated 26Capecitabine 19Docetaxel 16toripalimab 12Fluorouracil 11Radiotherapy 9Drug Therapy 8nedaplatin 6camrelizumab 6Induction Chemotherapy 5spartalizumab 4nimotuzumab 4Neoadjuvant Therapy 4Carboplatin 4tislelizumab 3Immune Checkpoint Inhibitors 3Chemoradiotherapy 3sintilimab 2cisplatin-guanosine adduct 2apatinib 2SSRP1 protein, human 2Radiation 2Injections 2Endostatins 2CF regimen 2streptococcal preparation 722 1penpulimab 1lobaplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Nasopharyngeal Carcinoma × Immunotherapy × Clear all
NCT06228079 2025-07-04

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Eye & ENT Hospital of Fudan University

Phase 3 Recruiting
176 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡